Soleno Therapeutics Inc. buy Guggenheim
Start price
07.08.25
/
50%
€69.15
Target price
07.08.26
€90.90
Performance (%)
-15.91%
Price
07:35
?
Summary
This prediction is currently active. The prediction for Soleno Therapeutics Inc. disappoints with a performance of -15.91%. This prediction currently runs until 07.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | 0.375% | 0.375% |
| iShares Core DAX® | -2.020% | 1.679% |
| iShares Nasdaq 100 | -1.647% | 2.940% |
| iShares Nikkei 225® | 1.146% | 6.353% |
| iShares S&P 500 | -1.323% | 1.950% |
Comments by Guggenheim for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Guggenheim from $97.00 to $106.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Guggenheim for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.30
27.08.25
27.08.25
€91.11
27.08.26
27.08.26
-1.94%
07:35
07:35
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€67.90
08.05.25
08.05.25
€85.63
08.05.26
08.05.26
-14.36%
07:35
07:35
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€65.90
28.03.25
28.03.25
-
28.03.26
28.03.26
-11.76%
07:35
07:35
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.30
21.11.23
21.11.23
€36.55
21.11.24
21.11.24
106.38%
22.11.24
22.11.24